The shift toward human-relevant research models continues to gain momentum.
In a recent announcement, the National Institutes of Health (NIH) committed $150 million toward advancing human-based research approaches, with the goal of reducing reliance on animal models. This investment reflects a broader movement across regulatory agencies, research institutions, and industry leaders to adopt more predictive, physiologically relevant testing methods.
Why This Matters
Traditional animal models have long played a role in preclinical research, but they come with known limitations in predicting human responses. As a result, there is increasing interest in New Approach Methodologies (NAMs), including organ-on-chip systems, organoids, and advanced in vitro models.
NIH’s investment signals continued support for:
- Improving translational relevance in early-stage research
- Accelerating drug development timelines
- Reducing ethical and regulatory challenges tied to animal testing
A Broader Industry Shift
This announcement aligns with ongoing efforts from organizations like the FDA, which has also emphasized the role of NAMs in modernizing drug development.
Together, these initiatives point toward a future where:
- Human-based models play a larger role in safety and efficacy testing
- Researchers have access to more predictive tools earlier in development
- Regulatory pathways continue evolving to support these technologies
Where Organ-on-Chip Fits In
Among the technologies gaining traction, organ-on-chip systems are emerging as a powerful tool for replicating human physiology in controlled laboratory environments.
Through our work with Dynamic42, Ohio Lumex supports access to organ-on-chip platforms that enable researchers to model organ-level functions and interactions with greater biological relevance. These systems are increasingly being explored as part of the broader shift toward NAMs and human-based research approaches.
Looking Ahead
As funding, regulatory guidance, and technological capabilities continue to advance, adoption of human-based research models is expected to grow.
For organizations working in life sciences, staying informed on these developments is essential—not only to remain competitive, but to take advantage of new opportunities in research and development.
Interested in how organ-on-chip technology fits into this evolving landscape?
Explore emerging approaches to human-based research
